Patient Stakeholder Groups Rethink Models for Addressing Unmet Needs

Patient Stakeholder Groups Rethink Models for Addressing Unmet Needs »

Earlier this month at the BioPharm America conference, the industry tipped its hat to increasingly powerful patient groups with their panel “Investments by Patient Groups and Other Stakeholders.” The panel discussed both the best practices and challenges associated with the shifting stakeholder landscape.

Send this to a friend